22nd Annual Conference of BHIVA Presentations - Thursday 21 April 2016

Download Final Programme Date: 19 - 22 April 2016

Venue: Manchester Central, UK

Presentations

Supporting Women with HIV Information Network (SWIFT) Workshop

The future for women living with HIV

Dr Yvonne Gilleece
Royal Sussex County Hospital, Brighton

Miss Laura Kwardem
Ourspace, Peterborough

Miss Angelina Namiba
Salamander Trust

Dr Shema Tariq
Mortimer Market Centre, London

BHIVA Invited Lecture 2

Professor Charles Lacey Anal cancer prevention strategies including screening for HPV-related diseases in HIV-positive patients
Professor Charles Lacey, University of York

MRC Clinical Trials Unit Session

Dr Alejandro Arenas-Pinto Evidence from the START trial and sub-studies: impact of early ART initiation on end-organ disease and other serious non-AIDS-defining conditions
Dr Alejandro Arenas-Pinto, MRC Clinical Trials Unit, London

Oral Research Presentations: Session 2 - Clinical and pathological

Dr Ramya Ramaswami Abstract O7: Outcomes of autologous stem cell transplantation in patients with relapsed/refractory HIV- associated lymphoma
Dr Ramya Ramaswami, Chelsea and Westminster Hospital, London

Dr John McSorley Abstract O8: HPV vaccination acceptability, uptake and completion in younger men who have sex with men in an HIV-positive cohort
Dr John McSorley, London North West Healthcare NHS Trust

Dr Corinna Sadlier Abstract O9: Prevalence, type and factors associated with HPV infection at multiple sites in young HIV- positive MSM
Dr Corinna Sadlier, St James's Hospital, Dublin, Ireland

Dr Paul Collini Abstract O10: Healthy HIV-1-seropositive individuals have impaired alveolar immunity despite highly active antiretroviral therapy
Dr Paul Collini, University of Sheffield

Dr Karen Rogstad Abstract O11: Interventions to improve screening for latent TB: effectiveness and outcomes
Dr Karen Rogstad, Sheffield Teaching Hospitals NHS Foundation Trust

Dr Jonathan Underwood Abstract O12: Brain MRI changes associated with poorer cognitive function despite suppressive antiretroviral therapy
Dr Jonathan Underwood, Imperial College London

Dr Keerthi Mohan Abstract O13: What is the overlap between HIV and shigellosis epidemics in England?
Dr Keerthi Mohan, Public Health England

Professor Mark Nelson Abstract O14: Ledipasvir/sofosbuvir for 6 weeks in HIV-infected patients with acute HCV infection
Professor Mark Nelson, Chelsea and Westminster Hospital, London

Dr Alessia Dalla Pria Abstract O15: Relapse of multicentric Castleman’s disease following rituximab-based therapy in 82 PLWH
Dr Alessia Dalla Pria, Chelsea and Westminster Hospital, London

BHIVA Lunchtime Workshop 3

HIV Clinical Dashboard
Dr Valerie Delpech, Public Health England

BHIVA Lunchtime Workshop 4 - Contributing to the peer community: what are the opportunities and challenges for new consultants?

The path from Consultant to research, mobile apps, Chair of website working group
Dr Gabriel Schembri, Manchester Centre for Sexual Health

The path from Consultant to Conferences Subcommittee Chair
Dr Chloe Orkin, Barts Health NHS Trust, London

The path from Consultant to research
Dr Julie Fox, Guy's & St Thomas' NHS Foundation Trust, London

Oral Research Presentations: Session 3 - HIV testing and prevention

Dr Fionnuala Finnerty Abstract O16: Does the new migrant "jungle" camp in Calais meet the minimum standards for sexual and reproductive health in an emergency situation set down by the inter-agency working group (IAWG) in reproductive health?
Dr Fionnuala Finnerty, Brighton & Sussex University Hospitals NHS Trust

Dr Vivian D Hope Abstract O17: Factors associated with undiagnosed HIV infection among people who inject drugs in England, Wales and Northern Ireland, 2005–2014
Dr Vivian D Hope, Public Health England

Ms Marina Daskalopoulou Abstract O18: Condomless sex in HIV-diagnosed men who have sex with men in the UK: prevalence, correlates, and implications for HIV transmission
Ms Marina Daskalopoulou, University College London

Dr Michael Brady Abstract O19: Self-testing for HIV: initial experience of the UK’s first kit
Dr Michael Brady, King's College Hospital, London

Dr Owen Seddon Abstract O20: Are laboratory specialties recommending HIV testing for suggestive results and is anyone listening?
Dr Owen Seddon, University Hospital of Wales, Cardiff

Mr Joel Paparello Abstract O21: Reducing the barriers to HIV testing – a simplified consent pathway increases the uptake of HIV testing in a high-prevalence population
Mr Joel Paparello, Guy's and St Thomas' NHS Foundation Trust, London

Dr Hannah Alexander Abstract O22: A calculation of the financial impact of opt-out HIV testing in a London Emergency Department (ED)
Dr Hannah Alexander, King's College Hospital, London

Dr Martina Toby Abstract O23: The Pre-exposure Prophylaxis (PrEP) Clinic at a central London sexual health service – the first 6 weeks
Dr Martina Toby, Chelsea and Westminster Hospital, London

Dr Monica Desai Abstract O24: Baseline predictors of HIV Infection in the no-PrEP group in the PROUD trial
Dr Monica Desai, Public Health England

BHIVA Audit Session

Professor Margaret May Does adjustment for patient mix affect the results of the BHIVA National Audit 2015?
Professor Margaret May, University of Bristol

BHIVA Plenary Session 3

Dr Laura Waters Managing steroids and antiretroviral therapy
Dr Laura Waters, Mortimer Market Centre, London

Dr Rashida Ferrand HIV and the lung: bronchiectasis, COPD, LIP – the facts
Dr Rashida Ferrand, Biomedical Research and Training Institute, Harare, Zimbabwe

Dr Lucy Garvey NAFLD (Non-alcoholic fatty liver disease): an emerging problem
Dr Lucy Garvey, Imperial College Healthcare NHS Trust, London

This educational session is funded by an independent educational grant from ViiV Healthcare. ViiV Healthcare does not have any involvement in speaker selection or content of this session.